Back

Innovations in Retinal Vascular Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing

Innovations in Neovascular Retinal Diseases: Enhancing Patient Outcomes Through Longer-Acting Therapies and Precision Dosing

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Mar 4, 2026
  • Last day to claim credit
    Apr 4, 2027 6 months left